Cited by 19Thyroid Disorders and TreatmentsAnalytical Methods in PharmaceuticalsPharmaceutical studies and practices

A new formulation of levothyroxine engineered to meet new specification standards

Lipp, Hans-Peter, Hostalek, Ulrike·2019·Current Medical Research and Opinion

Abstract

Background: Small variations in the dose of levothyroxine have been associated with marked variations in thyroid function in people with hypothyroidism. Accordingly, regulators have identified levothyroxine as a “narrow therapeutic index” drug subject to more stringent regulations compared with other drugs, in terms of the accuracy and stability of the amount of active drug in each tablet (typically required to be 95–105% of the labelled amount over its full shelf life), and its bioavailability geometric mean ratios (90% confidence intervals between 90–111.1%, including 100%).Review: This review describes a reformulation of a widely used levothyroxine product (Euthyrox.*). The new tablet fulfils all criteria according to the new specification regulations for dosage accuracy over a shelf life of 3 years in all climate zones, and for bioequivalence compared to the conventional formulation used for many years. In addition, a clinical trial demonstrated equivalent exposure between three different tablet strengths of the new formulation, amounting to the same total dose (dose form proportionality). As a consequence, switching from the conventional to the new formulation can be undertaken on a 1:1 dose-for-dose basis, without re-titration or additional thyroid function testing.Conclusion: The new formulation, which is more stable, will assist in the accurate dosage and titration of levothyroxine in the management of hypothyroidism.

Integrity signals

Registry

Crossref · 10.1080/03007995.2018.1545635

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lipp, H.-P., & Hostalek, U.
Affiliations
  • Universitätsklinikum Tübingen (DE)
  • Global Medical Affairs, Merck KGaA, Darmstadt, Germany
Venue
Current Medical Research and Opinion
Published
2018-11-26
Volume
35
Issue
1
Pages
147-150
ISSN
  • 0300-7995 (ISSN-L)
  • 1473-4877
OpenAlex
W2899749134
Cited by
19
References
17
Citations by year
2025: 1 · 2024: 3 · 2023: 1 · 2022: 4 · 2021: 6 · 2020: 2 · 2019: 2
FWCI
2.00
Type
journal article
Language
en
Open access
closed
Locations
  • Current Medical Research and Opinion (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Physical Sciences › Chemistry › Analytical Chemistry › Analytical Methods in Pharmaceuticals
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
Keywords
levothyroxine, drug reformulation, hypothyroidism, bioequivalence, dose accuracy, drug stability, narrow therapeutic index, thyroid function, bioavailability
MeSH terms
Biological Availability, Humans, Hypothyroidism, Tablets, Therapeutic Equivalency, Thyroxine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review